NCT00131872View on ClinicalTrials.gov

Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts

PHASE2TerminatedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

November 30, 2006

Conditions
End Stage Renal Disease
Interventions
DEVICE

Expedial Vascular Access Graft

Trial Locations (8)

10461

Montefiore Medical Center, The Bronx

Vascular Surgery, The Bronx

27710

Duke University Medical Center, Durham

29003

General Surgery, Bamberg

29605

South Carolina Associates for Cardiac and Vascular Disease; Greenville Hospital System, Greenville

33125

Vascular and General Surgery, Miami

70809

Vascular Surgery Associates, Baton Rouge

78206

Peripheral Vascular Associates, San Antonio

Sponsors

Lead Sponsor

LeMaitre Vascular
All Listed Sponsors
lead

LeMaitre Vascular

INDUSTRY

NCT00131872 - Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts | Biotech Hunter | Biotech Hunter